Articles tagged with Bacterial Infections
Researchers have developed an antibody treatment that improves survival in rodent models of sepsis by targeting a protein called tetranectin. The therapy boosts survival even when started late after sepsis onset, suggesting its potential for treating severe bacterial infections and secondary sepsis in COVID-19 patients.
Researchers identified bacterial exchange of genes allowing resistance to antibiotics, highlighting the complex process and potential for frequent sharing in hospital settings. The study's findings have implications for designing new strategies to prevent and control multidrug-resistant bacterial infections.
Cells in vulnerable entry routes to bacterial infection buffer themselves when immune system detects danger by reorganizing surface cholesterol. This defense mechanism, identified by UTSW researchers, could offer new strategies for fighting infections without antibiotics.
A study by Kevin Schneider and colleagues found that the bacterial strain Xylella fastidiosa subsp. pauca could have significant economic impacts on olive tree cultivation in Greece, Italy, and Spain. Replanting with resistant varieties or removing infected plants can mitigate these losses.
A recent study led by the Murdoch Children's Research Institute found that Fijians carrying a pneumonia-causing bacteria are more likely to be of iTaukei ethnicity, young, living in urban areas, or with low family income. The study also linked toddlers and children under six years old to a higher burden of pneumococcal bacteria.
The NHS could save up to £89 million annually by implementing widely available diagnostic tests, reducing unnecessary antibiotic prescriptions. The study found that 80-90% accurate point-of-care tests can help distinguish between bacterial and viral infections.
Researchers have developed a platelet-rich plasma lysate that, when teamed with antibiotics, can eradicate bacterial biofilms common in joint infections. The therapy has shown great results in horses and may also be applied to humans and dogs.
Researchers from University of Jyväskylä uncovered historical data on phage therapy's successful use against dysentery and staphylococcal infections in Brazil. The study sheds light on the revived interest in phage therapy as an alternative to antibiotics in the fight against antimicrobial resistance.
Researchers found that the abundance of Lactobacillus iners was associated with clearance of high-risk HPV infections, while Gardnerella bacteria were linked to progression to precancer. Monitoring Gardnerella and microbial diversity could help identify women at risk for pre-cancer.
Infections are responsible for one in five childhood deaths in England and Wales, with respiratory infections leading the way. The proportion of deaths caused by infections has declined, but not among infants and young children, who saw a significant increase in cases.
A new study published in Scientific Reports found that cannabidiol (CBD) enhances the effect of antibiotics against Staphylococcus aureus bacteria, a major human pathogen. The combination of CBD and antibiotics showed a more powerful effect than using antibiotics alone, reducing the need for antibiotics to achieve the same outcome.
Researchers at Chalmers University of Technology developed antibacterial surfaces using graphite nanoplatelets, reducing bacterial infections by 99.99% and preventing antibiotic resistance. The surfaces are designed to kill bacteria without damaging healthy human cells.
Engineers created a tiny device to rapidly detect harmful bacteria in blood, allowing for prompt diagnosis and treatment of potentially deadly infections. The device can capture up to 86% of target bacteria, including E. coli, making it ideal for laboratory and healthcare settings.
Researchers at the University of Bonn have deciphered daptomycin's mode of action, blocking cell wall construction and leading to bacterial death. The study sheds light on the antibiotic's mechanism, paving the way for optimization and combination therapies against antibiotic-resistant bacteria.
A new consensus statement offers UTI treatment recommendations to reduce overdiagnosis and overtreatment, while protecting against antimicrobial resistance. The statement aims to help healthcare providers diagnose, treat, and prevent UTIs in PALTC residents, who face increased risks of bacterial colonization and infection.
Researchers suggest that infectious agents may play a role in Alzheimer's disease, challenging the current amyloid hypothesis. Recent studies have linked certain viruses and bacteria to AD pathology, sparking fresh interest in this unorthodox approach.
A bacterial superbug can prevent stem cells in the gut from regenerating the inner lining of the intestine, causing potentially severe disease. This damage impairs tissue repair and recovery from disease, particularly in older adults.
Fecal Microbiota Transplants (FMT) have shown high success rates in treating C.diff infection, with 78% of patients experiencing no recurrence of diarrhoea within 90 days. This treatment is particularly effective compared to antibiotics, which have lower success rates for relapsing infections.
A new study reveals unprecedented details of the bacterium Francisella tularensis' key membrane protein Flpp3, responsible for its virulence. The researchers used X-ray free electron laser technology to gather detailed structural information, which will help develop targeted drugs and effective vaccines against tularemia.
Researchers developed a novel treatment that compacts and stabilizes neutrophil extracellular traps (NETs) to enhance bacterial capture, resist degradation, and improve sepsis outcomes. The treatment improved survival in mice with sepsis by reducing severity of illness and decreasing bacteria levels.
Perturbation of gut microbiota by influenza virus promotes secondary bacterial superinfection in mice. Treatment with acetate corrects this sensitivity.
Researchers discover potential superbug-killing compound AB569 that targets priority pathogens and additional bacteria causing foodborne illness. The compound has shown promising results in treating a wide range of infections, including those caused by Pseudomonas aeruginosa.
Researchers identified how Staphylococcus aureus and Staphylococcus epidermidis promote skin inflammation and barrier damage in Netherton syndrome. The study provides a detailed genomic description of the skin microbiome and offers a potential new treatment target by targeting the microbiome.
Researchers have identified a rare immune cell type that expresses both alpha-beta and gamma-delta T-cell receptors, which can both protect against infection and trigger autoimmune responses.
Researchers at Temple University Health System have developed a new monoclonal antibody that can break apart communities of harmful bacteria, allowing for more effective treatment of infections. The therapy has shown promise in eradicating biofilms on medical devices and reducing the risk of sepsis.
A new study led by NYU College of Dentistry researchers found that vaping alters the oral microbiome, making users more prone to inflammation and infection. E-cigarette users were found to have different bacteria in their mouths compared to smokers and non-smokers.
A new paper-based device has been developed to enable quick diagnosis of bacterial infections at the point of care. The test uses lasers to identify the presence of bacteria and determine which antibiotic is most effective in treating it.
A team of researchers used a statistical technique to identify ecological risk factors affecting coral diseases, including growth anomalies and white syndromes. They found larger corals had higher disease risk, with certain conditions such as high fertilizer and pesticide runoff associated with growth anomalies.
Researchers developed AB569, a combination of acidified nitrite and disodium ethylenediaminetetraacetic acid, which killed Gram-negative and Gram-positive bacterial pathogens, including Pseudomonas aeruginosa. The agent was found to be nontoxic to human cells at bactericidal concentrations, suggesting a potential therapeutic agent for ...
Researchers discovered that immune cells count their neighbors before activating to avoid overreactions. This new understanding could lead to improved cancer immunotherapies and treatments for autoimmune diseases.
A new clinical trial has found that using more than one antibiotic to treat MRSA infection provides no health benefits and increases the risk of side effects. The three-year study involved over 350 patients and tested whether adding a second antibiotic improved health outcomes.
A new study found that the same bacteria are present in the dermis layer of skin across all ages and genders, contradicting the long-held assumption that each person's microbiome is unique. This discovery has significant implications for understanding skin disorders like eczema and psoriasis.
A new group of antibiotics, corbomycin and complestatin, have been discovered with a unique approach to killing bacteria by blocking the function of the bacterial cell wall. The researchers demonstrated its effectiveness in mice against drug-resistant Staphylococcus aureus infections.
A new UNLV study found that a high-carbohydrate diet nearly eliminated symptoms of Clostridioides difficile (C. diff) infections in mice, whereas high-fat/high-protein diets exacerbated the infection. The research suggests that diet may promote microbial groups that can be protective against C. diff even after antibiotics.
Research suggests that bacteriophages found in children's intestinal tracts may play a role in childhood stunting. The viruses affect bacterial communities in the gut, and altering these communities could help improve health. This discovery offers hope for developing new cost-efficient therapies.
A new study published in mSystems found that mice fed a high-protein, high-fat diet developed severe C. difficile infections, while those on a high-carbohydrate diet recovered. The researchers suggest that diet may promote protective microbial groups after antibiotics.
Researchers conducted a large trial of MRSA blood infections and found that combining two antibiotics was not more effective than using one alone, but led to more kidney injuries. The study's findings aim to guide best management for patients worldwide.
Researchers found that immune cells perceive each other's density to regulate their proliferation, leading to more efficient immune reactions. This mechanism could improve cancer immunotherapies by reducing the risk of excessive immune responses.
Researchers suggest new vaccines targeting all pneumococcal strains colonizing the nose and throat, irrespective of capsular type, will be needed to prevent meningitis. Emerging non-PCV type strains cause meningitis at least as severely as targeted types, highlighting the need for updated vaccination strategies.
Researchers found that 50% of lupus skin rashes contained high levels of Staphylococcus aureus bacteria. A protein called interferon increases the stickiness of staph to the skin. This discovery highlights the increased risk of infection and spreading in lupus patients.
A teenage girl's symptoms improved with treatment, but further testing revealed no evidence of infection, highlighting the potential health risks of vaping. The case report suggests that e-cigarettes may be a plausible cause of subacute epiglottitis, a life-threatening condition.
A Tufts University-led team discovered that embryonic brain signals direct the migration of immune cells to infection sites, significantly improving embryo survival rates. Without a brain, embryos are more susceptible to bacterial infections and succumb quickly.
Scientists aim to eliminate persister cells, causing chronic health issues like airway infections and tuberculosis, by targeting their formation mechanisms through self-digestion. By mapping the self-digestion-related mechanisms in E. coli, researchers hope to develop effective anti-persister therapeutics.
Researchers propose using genomic data and mathematical modelling to design vaccines for the specific geographic location where they will be used. This approach aims to minimize rates of pneumococcal disease, a serious infection that can cause pneumonia, sepsis, and bacterial meningitis.
A Northwestern University study found that 45% of antibiotic prescriptions for Medicaid patients lacked a clear reason, highlighting concerns about antibiotic overuse. The research used Medicaid claims data to determine the context in which antibiotics were prescribed, revealing gaps in current ambulatory stewardship policies.
A vegetarian diet may be associated with a lower risk of urinary tract infections (UTIs), according to a study published in Scientific Reports. The study found that the overall risk of UTIs was 16% lower in vegetarians than in non-vegetarians, with a greater reduction in men than women.
A new study maps TB immune responses in diverse models including genetically diverse mice and blood samples from adolescents with TB. The study reveals similarities and differences between human, mouse, and macaque responses, providing valuable insights for developing effective therapies.
Researchers have developed color-changing bandages that can sense drug-resistant and drug-sensitive bacteria in wounds and treat them accordingly. The bandages change color to indicate the type of bacteria present, allowing for targeted treatment with antibiotics.
A team of international scientists has created a global map of dengue transmission intensity and predicted that releasing infected mosquitoes with Wolbachia could reduce cases by up to 90%. The study also suggests that the Sanofi Pasteur dengue vaccine could reduce cases by up to 30%.
Commonly used TB vaccines differ significantly in live bacteria content and cytokine responses, sparking concerns about their equivalence. The study highlights the need for a large-scale clinical trial to standardize BCG vaccine formulations.
A study of 11,784 children found that 25% received suboptimal antibiotic treatments. The most common cases included 'bug-drug mismatch' and prolonged use after surgery. Healthcare providers often overlooked these cases due to limited review by antimicrobial stewardship programs.
Researchers have developed a new treatment that completely kills the bacterial infection causing severe decline in lung function and death in cystic fibrosis patients. The treatment combines three antibiotics with no side effects, improving quality of life and survival chances for infected CF patients.
Researchers have discovered a rare African-specific variant of the TP53 gene that causes iron accumulation in macrophages, leading to poorer responses to bacterial infections. However, this variant also improves response to malaria toxin, potentially offering protection against severe inflammation and disease severity.
Researchers identified a highly competitive bacterium in the gut microbiota that protects against enteric pathogens. This discovery offers new avenues for developing antibiotic-free treatments.
Researchers discovered how an antibiotic, vancomycin, forms a mucoadhesive complex with gut mucins, trapping it and prolonging its exposure to the infectious microbe. This finding could lead to delayed transit of the antibiotic, improving its effectiveness in treating debilitating gut infections like PE.
Scientists discovered that Mycobacterium bovis can survive and grow in small amoebae organisms found in soil and dung. The bacterium adapts to ambient temperatures and remains metabolically active, potentially explaining high transmission rates between animals.
Scientists at University of Gothenburg discovered a new species of antibiotic-resistant bacteria, Scandinavium goeteborgense, isolated from an infected wound. The bacteria exhibit novel genetic variants of resistance, highlighting the need for precise treatment choices.
A blood test using eight gene signatures can predict the onset of tuberculosis three to six months before symptoms appear. This finding could help target antibiotics and save lives, particularly by identifying individuals at risk of developing TB disease after being infected with the bacteria.
A new point-of-care diagnostic test has been developed using a biomarker called RC0497, which can differentiate infected individuals from healthy controls. The test shows promise in enabling early detection and timely treatment of this potentially deadly tick-borne disease.
UNSW researchers found that whooping cough bacteria are adapting to evade vaccine-generated immunity by producing more nutrient-binding proteins and fewer immunogenic proteins. A new vaccine is needed to protect vulnerable populations, particularly newborns and those with weakened immune systems.